Related references
Note: Only part of the references are listed.Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation
Ian A. Rowe et al.
LIVER TRANSPLANTATION (2016)
Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study
Michael P. Curry et al.
GASTROENTEROLOGY (2015)
Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation
Michael Charlton et al.
GASTROENTEROLOGY (2015)
Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent Hepatitis C After Liver Transplantation
Xavier Forns et al.
HEPATOLOGY (2015)
Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody
Laurent Mailly et al.
NATURE BIOTECHNOLOGY (2015)
Global Distribution and Prevalence of Hepatitis C Virus Genotypes
Jane P. Messina et al.
HEPATOLOGY (2015)
Structural Flexibility of a Conserved Antigenic Region in Hepatitis C Virus Glycoprotein E2 Recognized by Broadly Neutralizing Antibodies
Annalisa Meola et al.
JOURNAL OF VIROLOGY (2015)
Successful Anti-Scavenger Receptor Class B Type I (SR-BI) Monoclonal Antibody Therapy in Humanized Mice After Challenge With HCV Variants With In Vitro Resistance to SR-BI-Targeting Agents
Koen Vercauteren et al.
HEPATOLOGY (2014)
A prophylactic hepatitis C virus vaccine: A distant peak still worth climbing
Thomas F. Baumert et al.
JOURNAL OF HEPATOLOGY (2014)
HCV animal models and liver disease
Koen Vercauteren et al.
JOURNAL OF HEPATOLOGY (2014)
Curing Chronic Hepatitis C - The Arc of a Medical Triumph
Raymond T. Chung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
Ype P. de Jong et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Human Monoclonal Antibody MBL-HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study
R. T. Chung et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
An Alpaca Nanobody Inhibits Hepatitis C Virus Entry and Cell-to-Cell Transmission
Alexander W. Tarr et al.
HEPATOLOGY (2013)
Host-targeting agents for prevention and treatment of chronic hepatitis C - Perspectives and challenges
Mirjam B. Zeisel et al.
JOURNAL OF HEPATOLOGY (2013)
Glycan Shifting on Hepatitis C Virus (HCV) E2 Glycoprotein Is a Mechanism for Escape from Broadly Neutralizing Antibodies
Homer Pantua et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Blocking HCV entry as potential antiviral therapy
Koen Vercauteren et al.
FUTURE VIROLOGY (2012)
Mutations That Alter Use of Hepatitis C Virus Cell Entry Factors Mediate Escape From Neutralizing Antibodies
Isabel Fofana et al.
GASTROENTEROLOGY (2012)
A Human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo
Philip Meuleman et al.
HEPATOLOGY (2012)
(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry
Noemie Calland et al.
HEPATOLOGY (2012)
Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice
Krzysztof Lacek et al.
JOURNAL OF HEPATOLOGY (2012)
Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing Antibody
Jane A. Potter et al.
JOURNAL OF VIROLOGY (2012)
Structure of Hepatitis C Virus Envelope Glycoprotein E2 Antigenic Site 412 to 423 in Complex with Antibody AP33
Leopold Kong et al.
JOURNAL OF VIROLOGY (2012)
Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1
Leopold Kong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
Erick Giang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate
Zhen-yong Keck et al.
PLOS PATHOGENS (2012)
Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
Trevor J. Morin et al.
PLOS PATHOGENS (2012)
Griffithsin Has Antiviral Activity against Hepatitis C Virus
Philip Meuleman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The Green Tea Polyphenol, Epigallocatechin-3-Gallate, Inhibits Hepatitis C Virus Entry
Sandra Ciesek et al.
HEPATOLOGY (2011)
In Vivo Evaluation of the Cross-Genotype Neutralizing Activity of Polyclonal Antibodies Against Hepatitis C Virus
Philip Meuleman et al.
HEPATOLOGY (2011)
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors
Andrew J. Syder et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatitis C Virus Evasion Mechanisms from Neutralizing Antibodies
Caterina Di Lorenzo et al.
VIRUSES-BASEL (2011)
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation
Samira Fafi-Kremer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus
Teresa J. Broering et al.
JOURNAL OF VIROLOGY (2009)
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
Zhen-yong Keck et al.
JOURNAL OF VIROLOGY (2009)
Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain
Thomas Vanwolleghem et al.
HEPATOLOGY (2008)
Anti-CD81 Antibodies Can Prevent a Hepatitis C Virus Infection In Vivo
Philip Meuleman et al.
HEPATOLOGY (2008)
Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein
Ania M. Owsianka et al.
JOURNAL OF GENERAL VIROLOGY (2008)
In vitro selection of a neutralization-resistant hepatitis C virus escape mutant
Meital Gal-Tanamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Mansun Law et al.
NATURE MEDICINE (2008)
Determination of the human antibody response to the epitope defined by the hepatitis C virusneutralizing monoclonal antibody AP33
Alexander W. Tarr et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus
Daniel X. Johansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
Jan M. Pestka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo
Thomas Von Hahn et al.
GASTROENTEROLOGY (2007)
Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: Safety and antiviral activity
Eithan Galun et al.
JOURNAL OF HEPATOLOGY (2007)
Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV:: Results of a phase 2 randomized study
Thomas D. Schiano et al.
LIVER TRANSPLANTATION (2006)
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
AW Tarr et al.
HEPATOLOGY (2006)
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients
GL Davis et al.
LIVER TRANSPLANTATION (2005)
Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins
A Goffard et al.
JOURNAL OF VIROLOGY (2005)
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera
P Meuleman et al.
HEPATOLOGY (2005)
Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein
A Owsianka et al.
JOURNAL OF VIROLOGY (2005)
A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice
P Meuleman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Anti-HCV human immunoglobulins for the prevention of graft infection in HCV-related liver transplantation, a pilot study
B Willems et al.
JOURNAL OF HEPATOLOGY (2002)
Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2
A Owsianka et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Hepatitis C virus replication in mice with chimeric human livers
DF Mercer et al.
NATURE MEDICINE (2001)
Share Paper
